Dr Warwick Tong
Dr Warwick Tong is CEO of Cancer Therapeutics CRC in Melbourne, Australia. He brings more than 23 years’ experience of senior leadership in medical, clinical, commercial and business development in the major pharmaceutical and biotechnology sectors.
From 2005 to 2011 he was SVP, Development, for Surface Logix Inc, Boston USA. Previously he held positions at GlaxoSmithKline (GSK), including country, regional and global roles as Medical Director, Business Development Director and VP Commercial Strategy for Infectious Disease.
Before his pharmaceutical industry career Dr Tong worked in primary care medicine for 14 years, founding two medical clinics in New Zealand. He graduated as Senior Scholar in Medicine from the University of Auckland and has a postgraduate qualification in Public Policy from Victoria University, Wellington.